The findings reported herein clearly verify that metastatic ovarian cancer cells require higher BCL2A1 expression, facilitating tumor survival and progression in harsh tumor microenvironments (TMEs) with multiple stressful challenges [37]. Here, BCL2A1 is linked to ovarian cancer.